Streetbeat News

Price Targets

JCI

Citigroup analyst Andrew Kaplowitz has maintained a Neutral rating on Johnson Controls Intl (NYSE:JCI) and lowered the price target from $68 to $58.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 4:06 pm

XYL

Citigroup analyst Andrew Kaplowitz maintains a Neutral rating on Xylem (NYSE:XYL) and lowers the price target from $125 to $101.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 4:03 pm

C

VRT

Citigroup analyst Andrew Kaplowitz maintains a 'Buy' rating on Vertiv Holdings (NYSE:VRT) and raises the price target from $40 to $47.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 4:02 pm

ZLAB

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Zai Lab (NASDAQ:ZLAB) and maintained a $70 price target.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:58 pm

JNJ

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Johnson & Johnson (NYSE:JNJ) and maintained a price target of $215.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:56 pm

IMVT

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Immunovant (NASDAQ:IMVT) and maintained a $30 price target.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:55 pm

ACRS

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Aclaris Therapeutics (NASDAQ:ACRS) and maintained a price target of $38.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:53 pm

RIOT

Cantor Fitzgerald analyst Josh Siegler has reiterated an Overweight rating on Riot Platforms (NASDAQ:RIOT) and maintained a $19 price target.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:52 pm

PX

Oppenheimer analyst Chris Kotowski maintains an Outperform rating on P10 (NYSE:PX) but has lowered the price target from $16 to $15.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:46 pm

KKR

Oppenheimer analyst Chris Kotowski has maintained an 'Outperform' rating on KKR & Co (NYSE:KKR) but lowered the price target from $91 to $87.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:44 pm